TIAM
GOSS icon

TT International Asset Management’s Gossamer Bio GOSS Stock Holding History

TT International Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-938
Closed -$693K – 75
2021
Q1 		$693K Buy
+938
New +$757K 0.03% 55

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

TT International Asset Management's GOSS Position: Q2 2021 in Review

TT International Asset Management sold out of Gossamer Bio (GOSS) in Q2 2021, closing a stake of 938 shares — an estimated $693K sold.

TT International Asset Management first reported a position in GOSS in Q1 2021 and held it in 1 quarter. The position peaked at $693K in Q1 2021. 115 funds tracked by Wall St. Rank hold GOSS as of Q2 2021.

  • TT International Asset Management reported no remaining Gossamer Bio position as of Q2 2021 after selling out during the quarter.
  • TT International Asset Management sold 938 Gossamer Bio shares in Q2 2021, an estimated $693K.
  • TT International Asset Management first reported a position in Gossamer Bio in Q1 2021 and held it in 1 quarter.
  • TT International Asset Management's Gossamer Bio position peaked at $693K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2021.

Based on TT International Asset Management's 13F filing for Q2 2021, filed 6 Aug 2021.